TERT Genetic Mutations as Prognostic Marker in Glioma
Authors:
- 20 May 2016
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 54 (5) , 3665-3669
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Stanniocalcin-1, a new biomarker of glioma progression, is associated with prognosis of patientsTumor Biology, 2015
- Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locationsWorld Journal of Gastroenterology, 2015
- TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlationsBritish Journal of Cancer, 2014
- Expression level ofhTERTis regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastomaOncotarget, 2014
- Interleukins in glioblastoma pathophysiology: implications for therapyBritish Journal of Pharmacology, 2013
- Molecular pathogenesis of IDH mutations in gliomasBrain Tumor Pathology, 2012
- Alternative lengthening of telomeres: models, mechanisms and implicationsNature Reviews Genetics, 2010
- Ageing and Cancer: The Telomere and Telomerase Connection2001
- Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomasNature Genetics, 1998
- Telomerase activity in human germline and embryonic tissues and cellsDevelopmental Genetics, 1996